Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to assess whether increasing
doses of somatropin (Norditropin®) can maintain the initial increase in height velocity and
improve final height. This trial has two trial periods, a main period of 4 years and an
extension period until final height is reached.